Eurofins Scientific announced that it has successfully raised EUR 500m in its second senior unsecured Euro bond public issuance. The bonds have a seven-year maturity (due 27 January 2022) and will bear an annual coupon of 2.25% (ACT/ACT). The issue was more than three times over-subscribed. ... more
Eurofins signs agreement to acquire Lancaster Laboratories, Inc.
28-Feb-2011: Eurofins Scientific SE has signed a definitive agreement to acquire Lancaster Laboratories, Inc. from Thermo Fisher Scientific, Inc. for approximately US$200m, subject to post-closing adjustments.
With approximately 1,100 employees in the USA and Ireland, Lancaster is a leading provider of pharmaceutical product testing services and cGMP Quality Control (QC) in North America. In addition, it operates one of the leading environmental testing laboratories in the USA.
With this bolt on acquisition, the Eurofins Group becomes the global leader in this very stable and recurring business and significantly enlarges its North American footprint. It is a further expression of Eurofins’ commitment to serve the pharmaceutical and biotechnology industries with laboratory services of the highest quality and reliability.
Completion of the transaction is expected in the next 2-3 months and is subject to applicable regulatory approvals and customary closing conditions. Implied EV/EBITDA multiple is in-line with levels previously communicated for transactions of this size and Eurofins’ value-creation objectives. Given that Lancaster is already a single-site laboratory in the USA, no site consolidations or restructuring costs are foreseen as a result of this acquisition. Based on Lancaster’s historic profitability and budget for 2011, the transaction should be immediately margin and EPS accretive for Eurofins.
Eurofins Genomics has now achieved Good Laboratory Practice (GLP) certification for DNA sequencing services, the first genomic service provider in Germany to attain such qualification.Good Laboratory Practice is a required standard for laboratories conducting non-clinical safety studies, fo ... more
Eurofins Genomics, the genomics division of the Eurofins Scientific Group, has now established its own subsidiary in Austria. Customers will be served directly through Eurofins Genomics AT GmbH located in Vienna.The acquisition of the oligonucleotide synthesis and DNA sequencing businesses ... more
Eurofins Scientific SE announced the successful closing of the transaction to acquire 100% of Lancaster Laboratories, Inc. (Lancaster, PA, USA), following thorough review and consequent approval from all relevant regulatory bodies. Eurofins signed an agreement to acquire Lancaster from Ther ... more
Eurofins Scientific SE has signed a definitive agreement to acquire Lancaster Laboratories, Inc. from Thermo Fisher Scientific, Inc. for approximately US$200m, subject to post-closing adjustments. With approximately 1,100 employees in the USA and Ireland, Lancaster is a leading provider ... more
To answer the healthcare industry’s demand for better point-of-care (POC) diagnostics, Thermo Fisher Scientific Inc. and Samsung Electronics Co., Ltd. have formed a strategic collaboration. The companies will jointly design, develop and market new POC solutions in key applications, such as ... more
Thermo Fisher Scientific has developed a fast and robust ion chromatography (IC)-based method for the determination of chloride and sulfate in adenosine. Application Note 1075: Ion Chromatography Assay for Chloride and Sulfate in Adenosine demonstrates that this method supports high sample ... more
Thermo Fisher Scientific Inc. announced it has completed the acquisition of Prionics AG, a privately held animal health diagnostics company. “Combining Prionics under the Life Technologies’ brand is certainly a win-win, since the products and capabilities are highly complementary,” said Dr. ... more
Maximize results and reduce errors in food analysis with proven ASE methods for more extractions in less time using less solvent more
Developed for flexibility, modularity, and ease-of-use, the Dionex ICS-5000+ HPIC system combines highest chromatographic resolution with convenience more
Separating complex samples just got a lot easier with the integrated, biocompatible Vanquish UHPLC for better separations, more results and easier interaction more
The new Chromeleon 7.2 CDS release is the first CDS that combines separation (GC/IC/LC) and Mass Spectrometry (MS) in an enterprise environment more
Organizations have made significant investments in enterprise and laboratory tools, technologies and solutions to help improve productivity, better manage data/information and optimize their business processes. However, the reality is that most companies have not reaped the return on inves ... more
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. Thermo Fisher Scientific in Europe specializes in high ... more
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2Damaged DNA amplified
- 3Merck Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich
- 4Emerson acquires Cascade Technologies Ltd.
- 5Tattoo-like sensor can detect glucose levels without a painful finger prick
- 6Measurable for the first time: How bio molecules react to lack of space
- 7Making the most of a shitty situation
- 8Fluorescence spectroscopy using a smartphone
- 9The Waters ionKey/MS Technology Named a Top Innovation for 2014
- 10Seward appoints Dan Crothers as Managing Director
- Shining a light on quantum dots measurement
- Gold nanoparticles show promise for early detection of heart attacks
- The Waters ionKey/MS Technology Named a Top Innovation for 2014
- Tattoo-like sensor can detect glucose levels without a painful finger prick
- Beckman Coulter Genomics Receives Accreditation from College of American Pathologists